Debashish Paramanick | Pharmacology | Young Scientist Award

Young Scientist Award

Debashish Paramanick
Affiliation School of Medical and Allied Science KR Mangalam University
Country India
Scopus ID 57195588370
Documents 14
Citations 108
h-index 5
Subject Area Pharmacology
Event International Young Scientist Awards
Google Scholar qIOqa4kAAAAJ
ORCID 0000-0002-8036-4933

Debashish Paramanick

School of Medical and Allied Science KR Mangalam University, India

The Young Scientist Award profile recognizes the scholarly activities and emerging research contributions of Debashish Paramanick, a researcher affiliated with the School of Medical and Allied Science KR Mangalam University, India. His academic work is associated with the field of Pharmacology and related biomedical sciences, with measurable scholarly visibility reflected through publications, citations, and research dissemination metrics. The profile is presented in a neutral academic format and summarizes research achievements, scholarly outputs, and potential suitability for recognition through the International Young Scientist Awards.[1][2]

Abstract

This academic recognition profile summarizes the scholarly activities of Debashish Paramanick within the domain of Pharmacology. Available bibliometric indicators suggest active participation in scientific publication and citation networks. The profile highlights research productivity, publication record, research influence, and academic engagement relevant to early-career scientific recognition programs. The information presented reflects publicly accessible scholarly metrics and professional research identifiers that support transparent academic evaluation.[1][3]

Keywords

Young Scientist Award; Debashish Paramanick; Pharmacology; Biomedical Research; Scientific Publications; Citation Analysis; Scopus Author Profile; ORCID; Research Impact; Academic Recognition.

Introduction

Scientific recognition programs frequently evaluate researchers based on publication quality, citation performance, research visibility, and contributions to advancing knowledge within their respective disciplines. In Pharmacology, researchers contribute to understanding drug actions, therapeutic innovations, biological mechanisms, and healthcare improvement initiatives. Academic profiling provides a structured method for documenting research achievements and evaluating scholarly influence across global research ecosystems.[4][5]

Research Profile

Debashish Paramanick is affiliated with the School of Medical and Allied Science KR Mangalam University in India and maintains internationally recognized researcher identifiers through ORCID, Scopus, and Google Scholar. Such identifiers contribute to author disambiguation, citation tracking, and visibility within scholarly communication systems. The available research metrics indicate publication activity supported by citation engagement from the wider academic community.[1][2]

Metric Value
Scopus Author ID 57195588370
Documents 14
Citations 108
h-index 5

Research Contributions

Research contributions associated with the investigator are situated within Pharmacology and related biomedical disciplines. Scholarly activities include participation in scientific publication, dissemination of research findings, and engagement with interdisciplinary scientific discussions. Contributions in pharmacological sciences often support evidence generation, therapeutic exploration, and improved understanding of biological processes relevant to human health and medicine.[4]

Publications

Publication activity remains an important indicator of research productivity. Based on available bibliometric records, Debashish Paramanick has authored or co-authored multiple scholarly documents indexed within academic databases. Publication outputs contribute to scientific communication, knowledge dissemination, and scholarly collaboration within the biomedical research community.[1]

  • Indexed scholarly publications within recognized databases.
  • Research dissemination through peer-reviewed academic channels.
  • Citation-generating contributions to Pharmacology-related literature.
  • Research visibility through international scholarly identifiers.

Research Impact

Research impact may be assessed through citation counts, h-index values, publication influence, and visibility within scholarly databases. Citation metrics indicate that published work has been referenced by other researchers, reflecting engagement with the scientific literature. While quantitative indicators should be interpreted alongside qualitative contributions, available metrics suggest an active scholarly presence within the academic community.[1][5]

Award Suitability

The International Young Scientist Awards generally recognize emerging researchers demonstrating academic productivity, research engagement, and contributions to scientific advancement. Based on available publication records, citation indicators, and professional research profiles, Debashish Paramanick demonstrates characteristics commonly considered during scholarly recognition assessments. Final award determinations remain subject to the specific criteria, review processes, and evaluation standards established by the awarding organization.

Conclusion

This profile presents a structured overview of the academic achievements and scholarly indicators associated with Debashish Paramanick. Through publication activity, citation engagement, and participation in Pharmacology-related research, the researcher contributes to the broader scientific literature. The documented metrics and professional identifiers provide a transparent basis for academic visibility and recognition within contemporary research environments.[1][2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Debashish Paramanick, Author ID 57195588370. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195588370
  2. ORCID. (n.d.). ORCID Record for Debashish Paramanick.
    https://orcid.org/0000-0002-8036-4933
  3. Google Scholar. (n.d.). Scholar Citations Profile.
    https://scholar.google.com/citations?user=qIOqa4kAAAAJ&hl=en&oi=ao
  4. Goodman, L. S., & Gilman, A. (2018). The Pharmacological Basis of Therapeutics.
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences. DOI: https://doi.org/10.1073/pnas.0507655102

Divya Sharma | Pharmacology | Research Excellence Award

Research Excellence Award

Divya Sharma
Vellore Institute of Technology, India
Divya Sharma
Affiliation Vellore Institute of Technology
Country India
Scopus ID 59553841100
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology
Event International Young Scientists Award
ORCID 0009-0004-3376-0847

Divya Sharma is a researcher associated with Vellore Institute of Technology, India, with academic interests in pharmacology and related biomedical sciences. Her research profile reflects engagement in scientific studies addressing pharmaceutical sciences, therapeutic investigations, and interdisciplinary health-related research. Through scholarly publications and indexed research contributions, Sharma has participated in the advancement of scientific understanding within pharmacological and healthcare-oriented domains.[1]

Abstract

This article summarizes the academic profile and scholarly activities of Divya Sharma in the field of pharmacology. Her research contributions include publication-based investigations and interdisciplinary studies associated with pharmaceutical sciences and biomedical research. The profile highlights publication metrics, citation indicators, and academic participation relevant to contemporary scientific research practices.[2]

Keywords

  • Pharmacology
  • Biomedical Research
  • Pharmaceutical Sciences
  • Healthcare Research
  • Scientific Publications

Introduction

Pharmacology research contributes significantly to healthcare innovation and therapeutic development through scientific experimentation and evidence-based investigations. Researchers in this field support advancements in drug discovery, treatment evaluation, and biomedical understanding. Divya Sharma’s scholarly profile reflects participation in research activities connected with pharmaceutical sciences and scientific communication through academic publishing platforms.[3]

Research Profile

Divya Sharma is affiliated with Vellore Institute of Technology, India. Her documented academic metrics include four research documents, eight citations, and an h-index of two. Her academic work is primarily associated with pharmacology and interdisciplinary biomedical studies involving healthcare-related scientific investigations.[1]

Research Contributions

  • Participation in pharmacological and biomedical research studies.
  • Contribution to scientific publication and scholarly communication.
  • Research involvement in healthcare-oriented scientific investigations.
  • Engagement in interdisciplinary pharmaceutical science research initiatives.

Publications

The publication profile of Divya Sharma includes indexed scholarly articles associated with pharmacology and healthcare sciences. Her research output demonstrates participation in academic dissemination through recognized scholarly platforms and scientific databases. Citation indicators further reflect the visibility and accessibility of her published work within academic communities.[2]

Research Impact

The research impact associated with Sharma’s academic work is reflected through citation activity, publication records, and scholarly indexing metrics. Her work contributes to broader scientific discussions concerning pharmacological investigations and biomedical applications. The documented citation profile and research participation indicate continuing academic engagement in scientific research activities.

Award Suitability

Based on the available academic profile and research documentation, Divya Sharma demonstrates qualifications relevant to recognition under the International Young Scientists Award program. Her scholarly activities, research publications, and participation in pharmacology-focused scientific studies align with the objectives commonly associated with research excellence and young scientist recognition initiatives.[6]

Conclusion

Divya Sharma academic profile illustrates active participation in pharmacology and biomedical research through publications, citation-based contributions, and scholarly engagement. Her work reflects continuing involvement in scientific communication and healthcare-related investigations. The profile presented in this article provides a concise overview of her academic achievements and research-oriented contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Divya Sharma, Author ID 59553841100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59553841100
  2. Google Scholar. (n.d.). Publication and citation profile of Divya Sharma.
    https://scholar.google.com/citations?hl=en&user=VsCMB4QAAAAJ&view_op=list_works&authuser=1&gmla=AIqSsVuOD0ny7xiZ4GIdOG3Ysew9JTNbTucp0boEKBLSh7lhzv6rBFfsUcdfByyt0h1ZOtsgMYoS-wb1Sn3EVEao
  3. Orcid. (n.d.). Orcid author details: Divya Sharma, Author ID 0009-0004-3376-0847.
    https://orcid.org/0009-0004-3376-0847
  4. International Young Scientists Award. (n.d.). Award program and academic recognition criteria.
    https://youngscientistawards.com/

Lakshmanan Govindan | Pharmacology | Young Scientist Award

Dr. Lakshmanan Govindan | Pharmacology | Young Scientist Award

Sri Lakshmi Narayana Institute of Medical Sciences | India

Dr Lakshmanan Govindan is a dedicated researcher in Botany with expertise in medicinal plant studies and bioactive compound analysis. His research focuses on isolating and characterizing natural compounds with anticancer, antidiabetic, and antimicrobial potential. He has contributed extensively to scientific literature, including research articles, patents, and book chapters in the fields of biotechnology and phytochemistry. His work also explores green synthesis of nanoparticles and their biomedical applications. He actively engages in academic evaluation, research reviewing, and interdisciplinary scientific advancements. His scholarly impact is reflected in 575 citations across 574 documents, with 28 published works and an h-index of 7, demonstrating consistent contributions and recognition in his field.

Citation Metrics (Scopus)

600500

400

300

200

100

0

Citations
575

Documents
28

h-index
7

Β 


View Scopus Profile
View Orcid Profile
View Google Scholar Profile

Featured Publications

 

Ravi Prakash Degala | Pharmacology | Young Researcher Award

Dr. Ravi Prakash Degala | Pharmacology | Young Researcher Award

Pydah College of Pharmacy | India

Dr. Ravi Prakash Degala is a pharmaceutical researcher specializing in clinical research, pharmacotherapy, and pharmacovigilance with a focus on improving patient outcomes and drug safety. His research spans diverse areas including disease management, adverse drug reactions, oncology, cardiology, and evidence-based pharmacy practice. He has contributed over 35 research publications, along with patents, book chapters, and edited academic books, reflecting strong scholarly productivity. His research profile includes 145 citations, an h-index of 3, and an i10-index of 1, indicating steady academic impact. He is actively engaged in advancing pharmaceutical sciences through research, innovation, and academic contributions.


View Google Scholar Profile

Featured Publications


Recent Advances in Nanomedicine

– Journal of Pharma Insights and Research, 2025


A Review of Synthesis and Therapeutic Applications of Coumarin Derivatives

– Journal of Pharma Insights and Research, 2024


A Review of Industrial Applications of Green Chemistry

– Journal of Pharma Insights and Research, 2025


Pathophysiology and Therapeutic Management of Methemoglobinemia: A Review

– Journal of Pharma Insights and Research, 2025

Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science | Editorial Board Member

Dr. Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science
| Editorial Board Member

Peking University | China

Dr. Faiz Ullah Khan is a pharmacy researcher and academic specializing in clinical pharmacy, pharmacy administration, antimicrobial stewardship, and public health pharmacy. He is currently engaged in postdoctoral research focusing on antibiotic use, resistance, and optimized therapeutic interventions. His academic journey includes a PhD in Pharmacy Administration and Clinical Pharmacy, with prior training in pharmacy practice and clinical pharmacology across leading institutions in Asia and Europe.Dr. Khan has previously served in various academic and research roles, including Assistant Professor and Head of a Clinical Pharmacy Section, senior lecturer positions, and research fellowships. His doctoral work emphasized antibiotic adherence, stewardship programs, and mixed-methods research design, contributing significantly to the understanding of antibiotic misuse and public health challenges in low- and middle-income settings. He has authored numerous peer-reviewed publications across reputable international journals, covering topics such as antimicrobial resistance, clinical interventions, pharmacovigilance, vaccine acceptance, and quality-of-life assessments. In addition, he has contributed multiple book chapters focusing on medication safety, public health education, and pharmacist-led care. Dr. Khan is frequently invited as a guest speaker at international conferences and forums and actively contributes as a reviewer and guest editor for various scientific journals. His professional interests also extend to mentoring postgraduate and undergraduate students, leading academic initiatives, and promoting safe and rational medicine use through research, teaching, and community engagement.

Featured Publications

Muhammad, K., Saqlain, M., Muhammad, G., Hamdard, A., Naveed, M., Butt, M. H., … Khan, F. U. (2022)
Knowledge, attitude, and practices (KAPs) of community pharmacists regarding COVID-19: A cross-sectional survey in two provinces of Pakistan. Disaster Medicine and Public Health Preparedness, 16(5), 1864–1872.
https://doi.org/10.1017/dmp.2021.17 (If a DOI existsβ€”this is the correct DOI for the article.)

Khan, F. U., Khan, F. U., Hayat, K., Chang, J., Saeed, A., Khan, Z., Ashraf, M., … Fang, Y. (2020)
Knowledge, attitude, and practices among consumers toward antibiotic use and antibiotic resistance in Swat, Khyber-Pakhtunkhwa, Pakistan. Expert Review of Anti-Infective Therapy, 18(9), 937–946.
https://doi.org/10.1080/14787210.2020.1769477

Β Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., Malik, U. R., … Fang, Y. (2021).
Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International Journal of Environmental Research and Public Health, 18(3), 1320.
https://doi.org/10.3390/ijerph18031320

Dharmalingam Kirubakaran | Pharmacology | Young Scientist Award

Dr. Dharmalingam Kirubakaran l Pharmacology
| Young Scientist Award

Saveetha University | India

Dr. Dharmalingam Kirubakaran’s research focuses on the green synthesis of nanoparticles and their multifaceted biomedical applications, encompassing antioxidant, antibacterial, anti-inflammatory, antidiabetic, and anticancer activities. His work extensively explores plant-mediated nanoparticle synthesis using bioactive extracts from species such as Strobilanthes cordifolia, Acmella caulirhiza, Cajanus albicans, Lantana camara, and Mangifera indica, combining traditional phytochemistry with advanced nanotechnology approaches. Characterization techniques employed include UV-Visible spectrophotometry, Fourier Transform Infrared (FTIR) spectroscopy, X-ray Diffraction (XRD), Scanning and Transmission Electron Microscopy (SEM/TEM), Energy Dispersive Spectroscopy (EDAX), and Dynamic Light Scattering (DLS), ensuring comprehensive analysis of particle morphology, size, and stability. Complementing synthesis studies, his in vitro assessments encompass antibacterial activity against Gram-positive and Gram-negative bacteria, antioxidant assays such as DPPH, ABTS, Hβ‚‚Oβ‚‚, and FRAP, anti-inflammatory and antidiabetic evaluations, anticholinergic enzyme inhibition, and anticancer effects on multiple cell lines including MCF-7, A431, HeLa, and A549. Additional investigations include mosquito larvicidal bioassays, photocatalytic dye degradation, and ethnobotanical studies of medicinal plants. His publications reveal a strong emphasis on sustainable, plant-based nanomaterials for biomedical applications, with work on PVA–PEG and chitosan-based nanocomposites highlighting potential in food packaging, therapeutic interventions, and drug delivery. Collectively, his research integrates phytochemistry, nanotechnology, and pharmacological evaluation to advance environmentally friendly and biologically effective solutions for healthcare and environmental challenges.

Featured Publications

  • Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., … (2025). A comprehensive review on the green synthesis of nanoparticles: Advancements in biomedical and environmental applications. Biomedical Materials & Devices, 1–26.

  • Manimegalai, P., Selvam, K., Loganathan, S., Kirubakaran, D., Shivakumar, M. S., … (2024). Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata: Their characterizations and biological applications. Biomass Conversion and Biorefinery, 14(11), 12559–12574.

  • Kirubakaran, D., Selvam, K., Prakash, P., Shivakumar, M. S., Rajkumar, M. (2023). In-vitro antioxidant, antidiabetic, anticholinergic activity of iron/copper nanoparticles synthesized using Strobilanthes cordifolia leaf extract. OpenNano, 14, 100188.

  • Rajkumar, M., Presley, S. I. D., Govindaraj, P., Kirubakaran, D., Farahim, F., Ali, T., … (2025). Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and … Scientific Reports, 15(1), 3931.

  • Kirubakaran, D., Bupesh, G., Wahid, J. B. A., Murugeswaran, R., Ramalingam, J., … (2025). Green synthesis of zinc oxide nanoparticles using Acmella caulirhiza leaf extract: Characterization and assessment of antibacterial, antioxidant, anti … Biomedical Materials & Devices, 1–22.

Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

Mr.Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

 

πŸ‘¨β€πŸ« 🌾🌟Mr. Surapon Nochaiwong, a distinguished figure in pharmacoepidemiology and clinical epidemiology, serves as an academic staff member in the Department of Pharmaceutical Care at Chiang Mai University, Thailand. πŸŽ“ Holding a Doctor of Pharmacy (Pharm.D.) degree, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at the Faculty of Pharmacy.Nochaiwong’s educational journey includes a Pharm.D. from Chiang Mai University, a General Residency in Pharmacotherapy, and diplomas in Clinical Statistics and Clinical Epidemiology. His commitment to education and research makes him a respected figure in the academic and scientific community. πŸ”¬πŸŽ“

 

🌐 Professional Profiles

Affiliation/Community πŸ›οΈ

Pharmacoepidemiology and Statistics Research Center (PESRC) Faculty of Pharmacy, Chiang Mai University 50200 Department of Pharmaceutical Care Faculty of Pharmacy, Chiang Mai University 50200

Personal Statement 🌟

Surapon Nochaiwong earned his Doctor of Pharmacy (Pharm.D.) degree from Chiang Mai University, Thailand. Currently holding an academic position in the Department of Pharmaceutical Care, Faculty of Pharmacy, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at Chiang Mai University.

Since joining the Faculty of Pharmacy in 2012, Nochaiwong has actively contributed as a young scientist and principal investigator on over 10 extramurally funded local and national grants. He has an impressive publication record with more than 50 manuscripts and conference abstracts, accumulating over 800 citations in the international scientific community. His research interests span clinical epidemiology, pharmacoepidemiology, patient-reported outcomes in dialysis patients, and systematic review & evidence-based synthesis in nephrology and dermatology.

Areas of Expertise/Knowledge 🧠

Clinical Epidemiology, Pharmacoepidemiology, Dialysis, Chronic Pruritus, Patient-Reported Outcomes, Systematic Review and Knowledge Synthesis, Mental Health and COVID-19

Positions and Honors πŸ†

2021 – Present: Co-principal investigator, Government of Canada, the Canadian Institutes of Health Research (CIHR) Operating Grant: Emerging COVID-19 Research Gaps & Priorities, 2020 – Present: Principal investigator and head of the HOME-COVID-19 consortium, 2016 – Present: Head of the Pharmacoepidemiology and Statistics Research Center (PESRC), 2017 – Present: Head of the Thai Renal Outcomes Research (THOR) Investigators, 2019 – Present: Vice head of the Evidence-Based Synthesis in Dermatology (EBSD), 2015 – 2017: Co-principal investigator, Funded by Health Systems Research Institute of Thailand (HSRI) through National Research Council of Thailand (NRCT), 2013 – 2014: Principal investigator, Young Researcher Granted by Chiang Mai University

Education πŸ“š

Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Chiang Mai University, Thailand, General Residency in Pharmacotherapy, The College of Pharmacotherapy of Thailand, Thailand, Β Diploma in Clinical Statistics, Faculty of Medicine, Chiang Mai University, ThailandΒ Diploma in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Thailand

Work Experience πŸ‘¨β€πŸ’Ό

2012-Present: Faculty of Pharmacy, Chiang Mai University, Thailand This detailed information provides a comprehensive overview of Surapon Nochaiwong’s academic and research journey, along with his significant contributions and affiliations in the field of pharmacy and healthcare.

πŸ“šTop Noted Publication

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review

Psychological Resilience and Adverse Mental Health Issues in the Thai Population during the Coronavirus Disease 2019 Pandemic

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis